IMMUNOMODULATION BY TRANSFORMING GROWTH FACTOR 0
Mixed Lymphocyte Cultures (MLC). CTLs were generated in 5-d MLC by incubation in 24-well tissue culture plates (3524 ; Costar, Cambridge, MA) of 5 X 10 6 or 5 X 105 B6 responding spleen cells and 5 X 106 BALB/c stimulator spleen cells (irradiated 2,000 rad) per well in 2 ml of complete minimal essential medium (CMEM) consisting of Eagle's minimum essential medium supplemented with 0 .1 mM nonessential amino acids, 2 mM L-glutamine, penicillin (100 U/ml), and streptomycin (100 wg/ml) (Gibco, Grand Island, NY) and 10% heat-inactivated FCS (Hyclone Laboratories, Inc ., Logan, UT) .
CTL Assay. After 5 d of culture, the cells were harvested, washed three times in CMEM and tested for cytotoxic activity in a 4-h "Cr-release assay . P815 (DBA/2 mastocytoma, H-2d ; American Type Culture Collection, Rockville, MD) or LBRM-33-1A5B (B10 .BR lymphoma, H-2' ; A . Zlotnik, DNAX Research Institute for Molecular and Cellular Biology, Palo Alto, CA) were labeled with 150 jCi Na"Cr04 (5 MCi/ml ; Amersham Corp., Arlington Heights, IL) for 45 min at 37°C, followed by three washes in CMEM . 100 ,ul of target cells (10 5 cells/ml) and 100 u1 of effector cells at various concentrations were added in triplicate in 96-well round-bottom microtiter plates (Costar) . After 4 h of incubation at 37°C and 5% C02 in air, the supernatants were harvested (Skatron, Rockville, MD) and their radioactivity was determined in an automatic gamma counter (Micromedic Systems, Horsham, PA Detection ofMuTNF-a in Supernatants of the MLC. The quantity of MuTNF-a produced in the MLC was determined using the WEHI-164 clone 13, which is capable of detecting levels as low as 7 X 10'U/ml (0 .01 pg/ml) of MuTNF-a per milliliter (15) . Using WEHI-164 clone 13 as indicator cells, the cytotoxicity induced by MuTNF-a was determined by an MTT tetrazolium colorimetric assay as detailed previously (15) . The amount of MuTNF-a in test supernatants was calculated on the basis of cytotoxicity obtained in the presence of various dilutions of a rMuTNF-a standard . Data are expressed as units of TNF-a per milliliter .
The specificity of this assay for MuTNF-a was demonstrated by inhibiting the cytolytic activity of test supernatants with anti-rMuTNF-a antiserum produced in New Zealand rabbits . This antiserum developed by methods similar to those described for production of anti-rHuTNF-a antiserum (16) , had a neutralization titer of^-10 6 U/ml in the L-M bioassay (12) . Normal rabbit serum (NRS) was obtained from control New Zealand rabbits .
Results
Inhibition of CTL Generation by TGF-,B . When added to MLC, TGF-,B inhibited the generation of B6-anti-H-2'-specific CTL in a dose-dependent fashion ( Table   1 ) . The inhibitory effects were most pronounced when TGF-# was added during the first 24 h of the MLC (Fig . 1) . Less inhibition was observed when the addition was delayed for 48 h, and only a minimal effect was seen if the delay was more than 72 h . Similarly, at the doses tested TGF-# showed no inhibitory activity if included directly in the CTL assay . These data indicate that TGF-# inhibits CTL generation in a dose-dependent manner, and its mechanism of action appears to involve early stages of the MLC .
Inhibition of TNF-a Production by TGF-,B during MLC. Although a variety of in vitro immunoregulatory activities have been ascribed to TNF-a, studies examining the production of TNF-a during an MLC and the effects of altering endogenous TNF-a levels during CTL development have not been reported (8) (9) (10) . Moreover, our previous studies have shown that TGF-# can inhibit TNF-a production by murine macrophages (6) . Therefore, we considered it important .O Effect of TGF-0 on In Vitro CTL Generation FIGURE 2. Inhibition of TNF-a production during MLC by TGF-,6 . 300 ul were removed from replicate MLC at the times indicated, and assayed for TNF-a as described in Materials and Methods. MLC contained no TGF-0 (0), 0.1 ng TGF-,B/ml (0), or 1 .0 ng TGF-0/ml (0). The presence of 10 ,ug TGF-fl in the WEHI-164 MuTNF-a bioassay did not affect the measurement of MuTNF-a activity, while the presence of anti-rMuTNF-a antiserum reduced the detection of MuTNF-a to background levels . Standard errors for all determinations were <10% . Results are presented as mean of triplicate determinations of one of four representative experiments . No significant amounts of Culture Hours
MuTNF-a were produced by cultures containing B6 cells or irradiated BALB/c cells alone. to examine whether the inhibitory effects of TGF-0 on CTL development could in part be due to the inhibition of TNF-a production. The concentration of MuTNF-a was measured at various times during the first 48 h of MLC in the absence or presence of 1 .0 or 0 .1 ng/ml TGF-f. The data (Fig. 2) indicate that as early as 4 h after culture initiation,^-7 X 10-s U/ml (0.1 pg/ml) of TNF-a Effector :Target Cell Ratio FIGURE 3 . Effects of rMuTNF-a on CTL generation during suboptimal culture conditions . MLC were established at stimulator/responder ratios of 1 :1 (p) and 0.1 :1 (p). 10 U/ml rMuTNF-a was added on day 0 to MLC at a 0.1 :1 ratio (®) and at a 1 :1 ratio (/). Results are mean ± SE of triplicate determinations performed at an E/T cell ratio of 12 .5 :1 . Similar results were obtained at all E/T cell ratios tested (data not shown).
.56 :1
Percent specific "Cr release (± SE) at E/T ratios o£ can be detected and that TGF-0 suppresses the production of TNF-a in a dosedependent manner .
To determine if the suppression of MuTNF-a production was critical to the inhibitory activity of TGF-0 on CTL generation, exogenous rMuTNF-a was added to MLC in the absence and presence of TGF-# (Table 11 ) . The addition of 102 U/ml of rMuTNF-a to TGF-0-suppressed MLC significantly restored the CTL activity . These results are not due to any direct activity of rMuTNF-a on the P815 target cells since the viability ofthese cells was not affected by rMuTNFa doses as high as 105 U/ml. When rHuTNF-a was substituted for rMuTNF-a, reversal of TGF-# suppression was detected only at concentrations of 10 5 U/ml rHuTNF-a, and no activity was observed when rHuTNF-a was used at this same concentration (data not shown) . These results may indicate a species preference with regard to action of TNF-a in this context, as suggested in previous studies (11) .
Enhancement ofCTL Development by rMuTNF-a. Under the optimal conditions used in developing the CTLs, the addition of rMuTNF-a at the doses tested had only minimal enhancing activity . However, at a suboptimal responder/stimulator ratio (0 .1 :1), rMuTNF-a significantly enhanced both the proliferative response (data not shown) and CTL generation to H-2 d targets (Fig . 3) .
Inhibition of CTL Generation by Antibodies to rMuTNF-a . As our earlier studies demonstrated that rMuTNF-a can significantly enhance CTL development if added to MLC established at suboptimal stimulator to responder ratios, we considered it important to investigate whether antibodies to rMuTNF-a could inhibit CTL generation . As shown in Fig. 4 , the addition of rabbit polyclonal antibodies to rMuTNF-a, but not addition of NRS to MLC on day 0 significantly inhibited CTL generation, further supporting our data of the critical role of TNF-a during CTL development .
Discussion
We have investigated the effects of TGF-0 and rMuTNF-a on CTL generation and function . Our investigations have indicated that: (a) TGF-0 will inhibit, in a dose-dependent manner, CTL generation, but only when TGF-0 is added in the early stages of the MLC ; (b) TGF-,B does not inhibit the cytotoxic activity of CTL ; (c) TNF-a production, which can be detected as early as 4 h after the initiation of an MLC, is inhibited by TGF-#; (d) addition of rMuTNF-a to TGF-,l-inhibited MLC significantly reverses the inhibitory activity of TGF-)3; and (e) antibodies to rMuTNF-a significantly inhibit CTL development . These results show that TGF-0 does not inhibit CTL generation by nonspecific cytostatic or cytotoxic processes, since the addition of TGF-,Q to MLC for the final 72 h does not affect the CTL activity . Rather, TGF-0 appears to inhibit a differentiation step in the early development of CTL . In addition, similar results have been obtained with rHuTGF-(0 (the polypeptide sequence of mature human and porcine TGF-,Q is identical) indicating that the effects observed with the natural porcine preparation are mediated by TGF-0 alone, and not a contaminant (data not shown) (17) .
Previous studies have indicated that CTL generation involves the production IMMUNOMODULATION BY TRANSFORMING GROWTH FACTOR ,B of two or more lymphokines, including IL-2 (18) (19) (20) (21) . TGF-# has been shown to affect T cell activation by downregulating IL-2-R. expression (2) and thereby inhibiting T cell proliferation . Scheurich et al. (10) have reported that rHuTNFa can enhance the response to IL-2 by upregulating the expression of IL-2-R.
Our data indicate that TNF-a plays an important role in the generation of CTL, and that TGF-,8 may inhibit the development of such cells, at least in part, by inhibiting TNF-a production. Our data also demonstrate that, while the reversal ofTGF-# suppression is significant, it is not complete, regardless of the rMuTNFa dose used. 'This may point to multiple effects of TGF-,B on CTL generation, only some of which are reversible by TNF-a, and which require the presence of additional cytokines . In recent experiments, we have observed that IL-2, which induces TNF-a production, can also reverse TGF-# inhibition ofCTL generation (our unpublished observations) (22) . Thus, TGF-# may inhibit CTL generation directly by downregulating IL-2-R expression, or indirectly by preventing upregulation of this receptor by blocking TNF-a production . Studies are now under way to further investigate the role of TNF-a in CTL generation, and the suppression of that process by TGF-,B.
Summary
The immunoregulatory effects of transforming growth factor ,B (TGF-Q) and recombinant murine tumor necrosis factor a (rMuTNF-a) on CTL generation and activity were examined . The results demonstrate that TGF-,B, in a dosedependent manner, inhibited CTL generation but not CTL activity . The inhibitory effects were detected only when TGF-# was added within the first 48 h of the MLC . Little activity was seen when it was added thereafter, including the addition of TGF-# to the cytotoxicity assay . The production of TNF-a, which occurs during early phases of the MLC and which is inhibited in the presence of TGF-,B, appears to have an important regulatory role, as altering the levels of TNF-a in an MLC can significantly influence CTL development . The inhibitory effects of TGF-# on the MLC can be significantly reversed by the addition of rMuTNF-a to the cultures . These results demonstrate that TGF-,B can inhibit MLC and subsequent CTL generation at early stages of the reaction, and such inhibition may involve the suppression of TNF-a production .
